 |
|
|
|
Browse alphabetically for topics addressed in
medical policies:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Introduction | Table of Contents | Recent Updates | Contact Medical Policy Staff
Index
Last updated: (May 1, 2024)
G |
|
| Galvanic stimulation |
| gammaCore® non-invasive VNS (nVNS) system (electroCore LLC) |
| gammaCore Sapphire D™ (electroCore, LLC) |
| Gastric reflux surgery |
| Gastric
electrical stimulation |
| Gastric
pacemaker |
| Gastric
stimulation, obesity |
| Gastroesophageal reflux surgery |
| Gastroplasty,
endoscopic |
| Gastroplication,
endoscopic |
| Gatekeeper
Reflux Repair System |
| GBA |
| Gender confirmation |
| Gender dysphoria |
| Gender identity disorder; (GID) |
| Gender reassignment surgery |
| Gene |
| GeneSight® Analgesic Panel (AssureRx Health, Inc.) |
| GeneSight® MTHFR Test (AssureRx Health, Inc.) |
| GeneSight® MTHFR Test (AssureRx Health, Inc.) (when part of a panel) |
| GeneSight® Psychotropic Genetic Panel (AssureRx Health, Inc.) |
| GeneSight® ADHD Test (AssureRx Health, Inc.) |
| Genetic
testing |
| Genetically engineered T cells |
| GeneTrails® AML/MDS Genotyping Panel (OHSU, Portland, OR) |
| GeneTrails® Solid Tumor Panel (OHSU) |
| Genomic Unity® AR Analysis (Variantyx Inc.) |
| Genomic Unity® Ataxia Repeat Expansion and Sequence Analysis (Variantyx Inc.) |
| Genomic Unity® Comprehensive Ataxia Repeat Expansion and Sequence Analysis (Variantyx Inc.) |
| Genomic Unity® DMD Analysis (Variantyx Inc.) |
| Genomic Unity® Exome Plus Analysis – Comparator (Variantyx Inc.) |
| Genomic Unity® Exome Plus Analysis – Proband (Variantyx Inc.) |
| Genomic Unity® Whole Genome Analysis – Comparator (Variantyx Inc.) |
| Genomic Unity® Whole Genome Analysis – Proband (Variantyx Inc.) |
| Genomic Unity® AR Analysis (Variantyx Inc.) |
| Genomic Unity® CACNA1A Analysis (Variantyx Inc.) |
| Genomic Unity® CACNA1A Analysis (Variantyx Inc.) |
| Genomic Unity® Cardiac Ion Channelopathies Analysis (Variantyx Inc.) |
| Genomic Unity® CSTB Analysis (Variantyx Inc.) |
| Genomic Unity® CSTB Analysis (Variantyx Inc.) |
| Genomic Unity® FXN Analysis (Variantyx Inc.) |
| Genomic Unity® FXN Analysis (Variantyx Inc.) |
| Genomic Unity® Lynch Syndrome Analysis (Variantyx Inc.) |
| Genomic Unity® MECP2 Analysis (Variantyx Inc.) |
| Genomic Unity® MECP2 Analysis (Variantyx Inc.) |
| Genomic Unity® PTEN Analysis (Variantyx Inc.) |
| Genomic Unity® PTEN Analysis (Variantyx Inc.) |
| Genomic Unity® SMN1/2 Analysis (Variantyx Inc.) |
| Genomic Unity® SMN1/2 Analysis (Variantyx Inc.) |
| GERD |
| Globus pallidus interna (GPi) |
| Glomerular filtration rate (GFR); transdermal, Transdermal GFR System (MediBeacon) |
| Graf
ligament |
| Growth
factors; wound healing |
| GRT LITE™ PRO-8A (GRT Solutions, Inc.) |
| Guardant360 Panel (Guardant Health) |
| Gynecomastia; surgical excision |
| GYNplus (Ambry Genetics) |
Comments from physicians and other health care practitioners regarding Asuris Medicare medical policies are welcome. If you are a physician and have a question or comment regarding a medical policy, please contact the medical policy staff through our secure form.
|
|
|
